DEXCOM, INC. (DXCM) Debt Components
- 2026-06-30: Convertible Notes Payable, CurrentUSD (m); Line of Credit Facility, Remaining Borrowing CapacityUSD $191.30M; Secured Debt, CurrentUSD (m); Long-term Line of CreditUSD (m).
- 2026-03-31: Convertible Notes Payable, CurrentUSD (m); Line of Credit Facility, Remaining Borrowing CapacityUSD $191.20M; Secured Debt, CurrentUSD (m); Long-term Line of CreditUSD (m).
- 2025-12-31: Convertible Notes Payable, CurrentUSD $0.00; Line of Credit Facility, Remaining Borrowing CapacityUSD $192.10M; Secured Debt, CurrentUSD (m); Long-term Line of CreditUSD (m).
- 2025-09-30: Convertible Notes Payable, CurrentUSD $1.21B; Line of Credit Facility, Remaining Borrowing CapacityUSD $192.30M; Secured Debt, CurrentUSD (m); Long-term Line of CreditUSD (m).
DEXCOM, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Line of Credit Facility, Remaining Borrowing Capacity USD | Secured Debt, Current USD | Long-term Line of Credit USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Line of Credit Facility, Interest Rate at Period End pure | Debt Instrument, Face Amount USD | Long-term Debt, Fair Value USD | Debt Instrument, Unused Borrowing Capacity, Amount USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $191.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $191.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $192.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.21B | $192.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.21B | $192.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.21B | $192.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.20B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $192.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $192.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $192.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $192.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $192.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $124.20M | $192.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $773.80M | $192.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $773.20M | $192.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $772.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $192.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $192.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $192.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $192.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $192.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $193.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $193.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $193.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $193.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $194.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $194.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $194.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $195.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $195.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $195.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $195.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $195.60M | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $195.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00M | (m) | (m) | $54.40M |
| 2018-06-30 | (m) | $195.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00M | (m) | (m) | $57.80M |
| 2018-03-31 | (m) | $195.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00M | (m) | (m) | $61.10M |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00M | (m) | (m) | $64.40M |
| 2017-12-31 | (m) | $200.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $200.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00M | (m) | (m) | $67.60M |
| 2017-06-30 | (m) | $200.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $400.00M | $409.70M | (m) | $70.70M |
| 2017-03-31 | (m) | $125.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.20% | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | $0.00 |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) |
| 2016-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $1.70M | (m) | (m) | $1.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $2.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | $2.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | $2.50M | (m) | $2.90M | $600.00K | $2.30M | (m) | (m) | (m) | (m) | (m) | $15.00M | (m) |
| 2015-06-30 | (m) | (m) | $2.40M | (m) | $3.50M | $1.20M | $2.30M | (m) | (m) | (m) | (m) | (m) | $15.00M | (m) |
| 2015-03-31 | (m) | (m) | $2.40M | (m) | $4.10M | $1.80M | $2.30M | (m) | (m) | (m) | (m) | (m) | $15.00M | (m) |
| 2014-12-31 | (m) | (m) | $2.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | $4.60M | $2.30M | $2.30M | (m) | (m) | (m) | (m) | (m) | $15.00M | (m) |
| 2014-09-30 | (m) | (m) | $2.30M | (m) | $5.20M | $600.00K | $2.30M | $2.30M | (m) | (m) | (m) | (m) | $15.00M | (m) |
| 2014-06-30 | (m) | (m) | $2.30M | (m) | $5.80M | $1.20M | $2.30M | $2.30M | (m) | (m) | (m) | (m) | $15.00M | (m) |
| 2014-03-31 | (m) | (m) | $2.20M | (m) | $6.30M | $1.70M | $2.30M | $2.30M | (m) | (m) | (m) | (m) | $15.00M | (m) |
| 2013-12-31 | (m) | (m) | $2.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | $6.80M | $2.20M | $2.30M | $2.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | $1.80M | (m) | $7.00M | $200.00K | $2.20M | $2.30M | $2.30M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $1.20M | (m) | $7.00M | $200.00K | $2.20M | $2.30M | $2.30M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | $700.00K | (m) | $7.00M | $200.00K | $2.20M | $2.30M | $2.30M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $200.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | $7.00M | $200.00K | $2.20M | $2.30M | $2.30M | (m) | (m) | (m) | (m) | (m) |
| 2012-11-30 | (m) | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.00M | (m) |
| 2011-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |